In that context, a good phase II result means a market cap surely north of $1b.
Getting a bit ahead of myself here, but what is LCT's position in terms of IP if they want to research the efficacy of this technology on Huntington's, Alzheimer's etc?
phase II Vs phase I, page-42
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.81M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $40.17K | 5.739M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 8577318 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 818948 | 1 |
View Market Depth
| Last trade - 15.39pm 11/11/2024 (20 minute delay) ? |
| 1AI (ASX) Chart |